Bhubaneswar: Procuring more COVID-19 vaccines is the need of the hour and that can happen only if more and more vaccine manufacturers are able to participate in the global tender floated by…
New Delhi: An expert panel of Drugs Controller General of India (DCGI) has permitted Bharat Biotech to administer a third dose of its COVID-19 vaccine Covaxin to a select group of volunteers…
New Delhi: Having refused permission earlier, the Drugs Controller General of India (DCGI) has now allowed Dr Reddy’s to conduct phase 2/3 clinical human trials of Russia’s Sputnik V vaccine…
New Delhi: An indigenous paper-strip COVID-19 diagnostic test, named after one of India’s most famous fictitious detectives 'FELUDA', recently received approval from the Drugs Controller…
New Delhi: There is a recommendation to grant permission to the Serum Institute of India (SII) to conduct the second and third phases of human clinical trials of the Oxford vaccine…
New Delhi: India’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis, for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute…
New Delhi: Even as COVID-19 cases are soaring in India, patients in the country are still to get Remdesivir, an experimental drug which has shown promise in treatment of coronavirus in other…